These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25544686)

  • 21. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
    Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
    Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of an in silico phospholipidosis prediction method using descriptors related to molecular interactions causing phospholipid-compound complex formation.
    Haranosono Y; Nemoto S; Kurata M; Sakaki H
    J Toxicol Sci; 2016 Apr; 41(2):321-8. PubMed ID: 26961617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis.
    Kuroda Y; Saito M
    Toxicol In Vitro; 2010 Mar; 24(2):661-8. PubMed ID: 19786086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-gradient PAMPA-based in vitro model assay for drug-induced phospholipidosis in early stage of drug discovery.
    Balogh GT; Müller J; Könczöl A
    Eur J Pharm Sci; 2013 Apr; 49(1):81-9. PubMed ID: 23439241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.
    Tilmant K; Gerets HH; Dhalluin S; Hanon E; Depelchin O; Cossu-Leguille C; Vasseur P; Atienzar FA
    Toxicol In Vitro; 2011 Oct; 25(7):1414-24. PubMed ID: 21515356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis.
    Rhein C; Löber S; Gmeiner P; Gulbins E; Tripal P; Kornhuber J
    J Neural Transm (Vienna); 2018 Dec; 125(12):1837-1845. PubMed ID: 30191367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of an in vitro screen for phospholipidosis using a high-content biology platform.
    Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ
    Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring the accumulation of fluorescently labeled phospholipids in cell cultures provides an accurate screen for drugs that induce phospholipidosis.
    Nioi P; Pardo ID; Snyder RD
    Drug Chem Toxicol; 2008; 31(4):515-28. PubMed ID: 18850360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
    van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
    Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds.
    Hanumegowda UM; Wenke G; Regueiro-Ren A; Yordanova R; Corradi JP; Adams SP
    Chem Res Toxicol; 2010 Apr; 23(4):749-55. PubMed ID: 20356072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.
    Atienzar F; Gerets H; Dufrane S; Tilmant K; Cornet M; Dhalluin S; Ruty B; Rose G; Canning M
    Toxicol Sci; 2007 Mar; 96(1):101-14. PubMed ID: 17175557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis.
    Lomuscio MC; Abate C; Alberga D; Laghezza A; Corriero N; Colabufo NA; Saviano M; Delre P; Mangiatordi GF
    Mol Pharm; 2024 Feb; 21(2):864-872. PubMed ID: 38134445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for the drug-phospholipid interaction: correlation to phospholipidosis.
    Alakoskela JM; Vitovic P; Kinnunen PK
    ChemMedChem; 2009 Aug; 4(8):1224-51. PubMed ID: 19551800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
    Sawada H; Takami K; Asahi S
    Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How does the quality of phospholipidosis data influence the predictivity of structural alerts?
    Przybylak KR; Alzahrani AR; Cronin MT
    J Chem Inf Model; 2014 Aug; 54(8):2224-32. PubMed ID: 25062434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis.
    Zhang X; Yang L; Liu Y; Song Z; Zhao J; Chen D; Yu H; Li R; Wang Y; Yang K; Chen Y; Xia M; Zhang LW
    Toxicol Appl Pharmacol; 2018 Jun; 348():54-66. PubMed ID: 29678448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
    Fischer H; Atzpodien EA; Csato M; Doessegger L; Lenz B; Schmitt G; Singer T
    J Med Chem; 2012 Jan; 55(1):126-39. PubMed ID: 22122484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposome electrokinetic chromatography based in vitro model for early screening of the drug-induced phospholipidosis risk.
    Wang T; Feng Y; Jin X; Fan X; Crommen J; Jiang Z
    J Pharm Biomed Anal; 2014 Aug; 96():263-71. PubMed ID: 24814828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J
    Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular responses associated with dibucaine-induced phospholipidosis.
    Peropadre A; Fernández Freire P; Herrero O; Pérez Martín JM; Hazen MJ
    Chem Res Toxicol; 2011 Feb; 24(2):185-92. PubMed ID: 21261262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.